Regulatory Oversight, SPF Compliance and Lessons for Industry Australia relies on sunscreen more than most countries. Yet in 2025, a wave of reporting and consumer testing challenged a core assumption that the SPF printed on the label consistently reflects the protection delivered in real-world products. CHOICE testing reported that 16 of 20 sunscreens did not…
Modern global politics and economic uncertainty are reshaping pharmaceutical supply chains. Trade wars, tariffs, and geopolitical tensions have disrupted the flow of Active Pharmaceutical Ingredients (APIs), raw materials, and finished products. For therapeutic goods manufacturers, these challenges demand proactive strategies to maintain compliance, ensure continuity, and protect patient safety. Whilst international policy may be out…
The definition of technology transfer (TT) may vary depending on the type of TT. It is generally referred as bridge between academia and industry, though it may also involve transfer of knowledge within the industry. In the pharmaceutical industry, TT would very often include transfer of new product and process from development to manufacturing. It…
The pharmaceutical sector in Vietnam has witnessed substantial growth and transformations in the past two decades. Government health policies have played a pivotal role in accelerating the development of Vietnam’s pharmaceutical industry, leading to a significant increase in its market size—from USD 5.4 billion in 2018 to an estimated USD 6.5 billion in 2021. According…
What is the current number of medicinal cannabis prescriptions in Australia so far? In just a few years, the number of medicinal cannabis prescriptions through the Special Access Scheme B (SAS-B) has grown substantially. It still represents a small percentage of the overall Australian population who state they rely on cannabis for medicinal purposes. Only…
Naloxone Access Pilot Programs (FAQs) This article will review FAQs in relation to Naloxone Access Programs being rolled out in various jurisdictions, including the ‘Take Home Naloxone’ pilot program in Australia – and why these programs need your support. Disclaimer: This article is for education purposes only. This content is NOT for use for training…
After Mind Medicine’s very successful International Summit on Psychedelic Therapies for Mental Illness, I’m sure the nascent industry is ablaze with ideas and inspiration. The down-scheduling decision on MDMA and psilocybin is due to be released in Dec 2021, and one of the last things we were asked to do as participants of the summit…
“Reducing stigma, saving lives” is the final blog in the 10 blog series on overdose awareness and overdose prevention topics. Did you miss the latest overdose research and overdose statistics report, released on the 31st of August 2021 (International Overdose Awareness Day)? The 2021 overdose research report was compiled and published by John Ryan and…
Please complete the form on the PharmOut contact us page. We will get back to you within one business day.
Phone: +61 3 9887 6412
Email: info@pharmout.net
